# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Lake Street analyst Thomas Flaten maintains OptiNose (NASDAQ:OPTN) with a Buy and raises the price target from $3 to $4.
HC Wainwright & Co. analyst Matthew Caufield reiterates OptiNose (NASDAQ:OPTN) with a Buy and maintains $5 price target.
HC Wainwright & Co. analyst Matthew Caufield initiates coverage on OptiNose (NASDAQ:OPTN) with a Buy rating and announce...